Results 201 to 210 of about 115,087 (327)
NEUROPHARMACOLOGICAL ACTIONS OF TWO NEW ADRENERGIC BETA-RECEPTOR ANTAGONISTS, BUNOLOL AND H 64/52
N K Khanna +3 more
openalex +2 more sources
Beta adrenergic signaling as a therapeutic target for autoimmunity. [PDF]
Lauten TH +6 more
europepmc +1 more source
Abstract Individuals with persisting post‐concussion symptoms with physiological subtype (PPCS‐P) demonstrate exercise intolerance due to exacerbation of concussion‐like symptoms during incremental exercise. We tested the hypothesis that individuals with PPCS‐P (n = 12) would have a blunted cardiac autonomic response to face cooling compared to healthy
Phillip J. Wallace +6 more
wiley +1 more source
Central injection of epidermal growth factor (EGF) induces hypophagia via D₁ dopaminergic and β₂ adrenergic receptors in broiler chickens. [PDF]
Jafari-Ardakan Z +2 more
europepmc +1 more source
M, Kakenuma, T, Yoshikawa
openaire +1 more source
Abstract Over the past three decades, there has been a steady increase in clinical attention to ischaemic heart failure caused by coronary microembolization. Nonetheless, a suitable mouse model for studying this condition remains limited. In the present study, we developed a mouse model of coronary microembolization‐induced ischaemic heart failure by ...
Lang Pei +10 more
wiley +1 more source
K, Bato +3 more
openaire +1 more source
Beta-Adrenergic Antagonists Attenuate Somatic and Aversive Signs of Opiate Withdrawal
G. Harris, G. Aston-Jones
semanticscholar +1 more source
Abstract Central arterial stiffening, particularly of the proximal aorta, is increasingly recognised as a pivotal contributor to cardiovascular disease, dementia, and mild cognitive impairment. Loss of Windkessel function amplifies pulsatile pressure, reduces diastolic perfusion and accelerates microvascular damage in the brain.
Jun Sugawara, Hirofumi Tanaka
wiley +1 more source

